Valocor Therapeutics, Inc., a clinical stage biotech company, develops new therapies to treat dermatological conditions with unmet medical
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Vancouver
State: British Columbia
Zip:
Country: Canada
Valocor Therapeutics, Inc., a clinical stage biotech company, develops new therapies to treat dermatological conditions with unmet medical needs. Its products include Lemuteporfin, a potent and selective topical photodynamic therapy approach to sebaceous gland targeting for severe acne; VAL-001, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; VAL-002, a small-molecule kinase-inhibitor for topical treatment of chronic inflammatory skin diseases; and VAL-003, a Kinase inhibitor with dual melanin-stimulating and immune-modulating activities. Valocor Therapeutics, Inc. was founded in 2008 and is based in Vancouver, Canada.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2010 | Venture Round | 1 | - |
Matrix Asset Management Matrix Asset Management |
5/2010 | Venture Round | 1 | - |
Matrix Asset Management Matrix Asset Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|